Front Cell Infect Microbiol 8:13 Gao J, Mang Q, Sun Y, Xu G (2025) Short-Chain Fatty Acids (SCFAs) Modulate the Hepatic Glucose and Lipid Metabolism of Coilia nasus via the FFAR/AMPK Signaling Pathway In Vitro
For the purpose of the database, patent families are grouped by number (e.g., Family 1, 5, 30, etc.)
What are the side effects of GLP-1 therapy, and does microdosing reduce them
The SE, SP, PPV, and NPV of the optimal cutoff values (8.8 kPa) were 70.27%, 76.25%, 28.9%, and 94.9%, respectively
,
Maintaining Results After Long-Term Semaglutide Use Patients who have completed extended semaglutide therapy face a critical decision: continuing indefinitely, transitioning to a lower maintenance dose, or stopping with structured lifestyle support to prevent rebound weight gain